AN2 Therapeutics Inc (ANTX)

2.52 +0.13 (+5.44%) USD  |  NASDAQ  |  May 02, 14:28
More

AN2 Therapeutics Net Operating Interest Income (Quarterly)

Net Operating Interest Income (Quarterly) Chart

View Net Operating Interest Income (Quarterly) for ANTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Net Operating Interest Income (Quarterly) Data

View and export this data back to 2021. Upgrade now.
Date Value
December 31, 2021 --
September 30, 2021 --
Date Value
June 30, 2021 --
March 31, 2021 --

Net Operating Interest Income (Quarterly) Range, Past 5 Years

Upgrade
Minimum
Mar 2021
Upgrade
Maximum
Dec 2021
Upgrade
Average
Upgrade
Median

Net Operating Interest Income (Quarterly) Benchmarks

Gilead Sciences Inc Upgrade
QuidelOrtho Corp Upgrade
CymaBay Therapeutics Inc (DELISTED) Upgrade
Insmed Inc Upgrade
Revance Therapeutics Inc Upgrade